Glucagon infusion

OTHER4 trials

Sponsors

University Hospital, Gentofte, Copenhagen, The University of Texas Health Science Center at San Antonio, Nicolai Jacob Wewer Albrechtsen

Conditions

Chronic Kidney DiseasesGlucose MetabolismHyperglucagonemiaIncretin ActionInsulin SecretionInsulin SensitivityLiver CirrhosisObesity

Early Phase 1

Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism

CompletedNCT04300049

The University of Texas Health Science Center at San AntonioInsulin Sensitivity

Start: 2018-02-05End: 2023-11-15Updated: 2024-10-21

Unknown Phase

Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.

CompletedNCT01232244

University Hospital, Gentofte, CopenhagenIncretin Action, Obesity

Start: 2010-10-31End: 2012-01-31Updated: 2013-12-10

The Role of the Kidneys and Liver in the Elimination of Glucagon

CompletedNCT05056584

University Hospital, Gentofte, CopenhagenChronic Kidney Diseases, Hyperglucagonemia, Liver Cirrhosis

Start: 2020-08-01End: 2023-03-28Updated: 2023-05-12

The Glucose-Independent Effects of Exogenous Glucagon on Insulin Secretion and Cognitive Function in Healthy Subjects

RecruitingNCT06685146

Nicolai Jacob Wewer AlbrechtsenGlucose Metabolism, Insulin Secretion

Start: 2024-11-12End: 2025-10-31Target: 10Updated: 2024-12-18